香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何 部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 New Universe Environmental Group Limited 新宇環保集團有限公 司 （在開曼群島註冊成立之有限公司） 承董事會命 （股份代號：436） 對本公司作為擔保人提起之法律程序 本公佈由新宇環保集團有限公司（「本公司」）根據證券及期貨條例（第571章）第 XIVA部及香港聯合交易所有限公司證券上市規則第13.09條作出。 謹此提述本公司日期為二零二零年九月二十五日及二零二零年十月五日就有關向 柳州新宇榮凱固體廢物處置有限公司（「柳州新宇榮凱」）提供擔保之公佈。柳州新 宇榮凱為一家在中華人民共和國（「中國」）註冊成立之中外合資經營有限責任公司， 由本公司間接擁有其65%股本權益、及由廣西榮凱華源電鍍工業園投資有限公司 （「廣西榮凱」）直接擁有其35%股本權益。 於二零二零年九月二十五日，(i)柳州新宇榮凱與中國銀行股份有限公司柳州分行 （「中行柳州分行」）訂立貸款協議（連同其補 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新宇環保集團有限公司 FF301 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00436 | 說明 | | 新宇環保 | | | | | | | | 已發行股份（不包括庫存股份）數目 | | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | | 3,035,697,018 | | 0 | | 3,035,697,018 | | 增加 / 減少 (-) | | | | | | | | | | 本月底結存 | | | | 3,035,697,018 | | 0 | | 3,035,697,018 | 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 ...

Market Overview - The A-share market experienced a rise and then a pullback, with the Shanghai Composite Index up by 0.10% and the ChiNext Index up by 0.22% as of the midday close [1] - The trading volume reached 1.28 trillion CNY, with a predicted total turnover of 2 trillion CNY, indicating a decrease of 600 billion CNY [2] Index Performance - The Shanghai Composite Index closed at 3869.25, with a gain of 4.02 points or 0.10% [2][3] - The ChiNext Index closed at 2962.56, increasing by 6.58 points or 0.22% [2] - The total number of stocks that rose was 3,295, while 1,946 stocks fell [2] Sector Performance - The innovative drug sector showed strong rebounds, with stocks like Guangshengtang hitting a 20% limit up, and others like Shutaishen and Boteng shares also seeing significant gains [6][10] - The retail, domestic software, and pet economy sectors also performed well, while sectors such as rare earth, shipping, and aerospace military industries faced declines [6] Notable Stocks - Guangshengtang's stock price rose to 122.65 CNY, marking a 20% increase with a trading volume of 24.89 million shares [12] - Shutaishen's stock price increased by 14.40% to 36.87 CNY, with a trading volume of 47,747 shares [12] - Other notable stocks in the innovative drug sector included Boteng shares and Huahai Pharmaceutical, which also saw significant price increases [10][12] Consumer Sector - The consumer sector showed strength, with Guoguang Chain achieving three consecutive limit-ups, and other companies like Nanning Department Store and Kidswant also experiencing gains [14][17] - The meeting of economic experts emphasized the need for policies to stimulate domestic demand and enhance market vitality, which could benefit the consumer sector [17]

Core Viewpoint - The A-share market showed mixed performance with the innovation drug sector experiencing a strong rebound, while the consumer sector also performed actively [2][6][13]. Market Performance - As of the midday close on October 15, the Shanghai Composite Index rose by 0.10% to 3869.25, while the ChiNext Index increased by 0.22% to 2962.56 [2][3]. - The total trading volume reached 1.28 trillion CNY, with a predicted total of 2.00 trillion CNY, indicating a decrease of 600 billion CNY from previous estimates [3]. Sector Performance - The innovation drug sector saw significant gains, with stocks like Guangshentang rising by 20%, Shutaishen increasing by over 10%, and other companies like Boteng Co., Huahai Pharmaceutical, and Meidisi also showing strong performance [11][12]. - Conversely, sectors such as rare earths, shipping, and aerospace defense experienced declines, with notable drops in their respective indices [6][7]. Consumer Sector - The consumer sector showed strength, with companies like Guoguang Chain achieving three consecutive trading limits, and other firms such as Nanning Department Store and Gongxiao Daji also seeing increases [13][16]. Upcoming Events - The European Society for Medical Oncology (ESMO) annual meeting is scheduled from October 17 to 21 in Berlin, which is expected to showcase significant clinical research results in the oncology field [12].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新宇環保集團有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00436 | 說明 | 新宇環保 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000, ...

Financial Performance - Revenue for the six months ended June 30, 2025, was approximately HK$165,119,000, a decrease of 0.6% compared to approximately HK$166,070,000 for the same period in 2024[17]. - Net loss for the six months ended June 30, 2025, was approximately HK$13,509,000, a decrease of 43.0% compared to approximately HK$23,706,000 for the same period in 2024[17]. - Loss attributable to the owners of the Company for the six months ended June 30, 2025, was approximately HK$10,619,000, a decrease of 47.6% compared to approximately HK$20,248,000 for the same period in 2024[17]. - Basic loss per share attributable to owners of the Company for the six months ended June 30, 2025, was HK cents 0.35, compared to HK cents 0.67 for the same period in 2024[17]. - The Group recorded a pre-tax loss of approximately HK$17,156,000 for the industrial and medical waste services segment, an improvement from a pre-tax loss of HK$27,403,000 in 2024, indicating a reduction in losses by approximately 37%[27][28]. - Adjusted EBITDA for the six months ended June 30, 2025, increased by HK$8,199,000, reflecting a decrease in losses from core business segments[54]. - The loss for the period decreased to HK$13,509,000 in 2025 from HK$23,706,000 in 2024, representing a reduction of 43%[73]. - Adjusted EBITDA for the six months ended June 30, 2025, was HK$37,420,000, an increase of 28% from HK$29,221,000 in the same period of 2024[73]. Cash and Liquidity - Cash and cash equivalents of the Group as of June 30, 2025, were approximately HK$234,196,000, an increase of 6.1% compared to approximately HK$220,823,000 at December 31, 2024[17]. - The Group's liquidity position remains stable, with available unused unsecured banking facilities totaling HK$25,480,000 as of June 30, 2025[69]. - The total interest-bearing borrowings increased to HK$50,043,000 as of June 30, 2025, compared to HK$44,752,000 as of December 31, 2024, reflecting an increase of 12.9%[79]. - The current ratio improved to 1.46 times as of June 30, 2025, compared to 1.43 times as of December 31, 2024[80]. Revenue Segments - Total segment revenue from environmental treatment and disposal services for industrial and medical wastes was approximately HK$108,444,000, compared to HK$105,297,000 in 2024[18]. - For the six months ended 30 June 2025, the total revenue from the environmental treatment and disposal of industrial and medical waste services segment was approximately HK$108,444,000, compared to HK$105,297,000 in 2024, reflecting a year-on-year increase of 2%[20]. - Revenue from hazardous waste treatment and disposal services for the twelve months ended June 30, 2025, was approximately HK$227,401,000, with a total waste collected and disposed of 203,518 metric tons[58]. - The revenue from industrial sewage treatment and public utilities management services was HK$43,596,000 in 2025, down from HK$46,282,000 in 2024, indicating a decrease of approximately 5.5%[34]. - The leasing of factory buildings and facilities generated revenue of HK$13,079,000 in 2025, compared to HK$14,491,000 in 2024, reflecting a decline of approximately 9.8%[34]. Operational Metrics - The Group collected approximately 81,145 metric tonnes of hazardous wastes for treatment and disposal, an increase from 45,591 metric tonnes in 2024[18]. - The total waste collected and disposed of in the hazardous industrial waste segment was 41,586 metric tonnes in 2025, slightly down from 41,946 metric tonnes in 2024[20]. - The average utilisation rate of factory buildings and facilities decreased from 86.2% in 2024 to 80.1% in 2025[37]. - The average utilisation rate of sewage treatment capacity remained stable at around 22% for both 2024 and 2025[37]. - The Group's combined licensed waste treatment and disposal facilities capacity increased to 228,500 metric tonnes in 2025, up from 221,500 metric tonnes in 2024, representing a growth of approximately 3.5%[29]. Dividends and Shareholder Returns - The Board resolved not to declare a dividend for the six months ended June 30, 2025[17]. - Total dividends declared by Suzhou New Huamei, Danyang New Huamei, and Qingdao Huamei for 2024 amounted to approximately HK$3,704,000, slightly down from HK$3,745,000 in 2024[39]. - A final dividend of HK$0.0016 per ordinary share, totaling approximately HK$4,857,000, was recognized as a liability as of June 30, 2025, and paid on July 31, 2025[125]. Legal and Compliance Matters - The total accrued amount for legal claims from two plaintiffs was approximately HK$51,080,000 as of June 30, 2025, unchanged from December 31, 2024[101]. - The asset preservation order related to the legal proceedings will remain in effect until March 12, 2028, unless lifted earlier by the court[100]. - The ongoing lawsuit involves claims for unpaid dividends totaling approximately HK$26,579,000 per plaintiff, with additional interest claims[103]. - The property preservation order related to the lawsuit has been extended until March 12, 2028[103]. Employee and Management Information - As of June 30, 2025, the Group had 388 full-time employees, a decrease from 425 in 2024, with staff costs amounting to HK$32,024,000, down from HK$38,398,000 in 2024[105][106]. - There were no significant changes in the management team or directors' information during the reporting period[129][131]. - The Company has not made any significant changes to its principal risks and uncertainties since the last annual report for the year ended December 31, 2024[123]. Corporate Governance - The Company complied with all provisions of the Corporate Governance Code, except for the separation of roles between the Chairman and CEO, which are held by the same individual[140]. - The company believes that having the same individual serve as both Chairman and CEO enhances operational efficiency and decision-making[143]. - The company will continue to review the governance structure regarding the roles of the Chairman and CEO to ensure it aligns with best practices[143]. Share Options and Equity - As of January 1, 2025, the number of share options available for grant under the scheme was 260,109,701, which remained unchanged from December 31, 2024[146]. - No options were granted under the Share Option Scheme during the six months ended June 30, 2025[147]. - As of June 30, 2025, a total of 9,317,000 shares were vested under the Share Option Scheme, while 3,763,000 shares were cancelled due to unfulfilled vesting conditions[151]. - The options outstanding as of June 30, 2025, had a weighted average exercise price of HK$0.308, with 9,317,000 options remaining unexercised[154]. - The fair value of the remaining options granted on January 18, 2022, was approximately HK$1,092,000, with a total share option expense recognized of approximately HK$154,000 for the six months ended June 30, 2025[155]. Risks and Challenges - The Group continues to face challenges in the hazardous waste treatment market, with strategic measures significantly reducing net loss compared to the same period in 2024[42]. - The Group continues to face ongoing losses in the hazardous industrial waste treatment segment due to lower pricing pressures from manufacturing clients, particularly in Jiangsu Province, China[122].

呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00436 | 說明 | 新宇環保 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 100,000,000,000 | HKD | | 0.01 | HKD | | 1,000,000,000 | 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 新宇環保集團 ...

Group 1 - The company reported revenue of approximately HKD 165,119,000 for the six months ending June 30, 2025, representing a year-on-year decrease of 0.6% [1] - The loss attributable to the company's owners was approximately HKD 10,619,000, a reduction of 47.6% compared to the loss of approximately HKD 20,248,000 in the same period of 2024 [1] - The basic loss per share attributable to the company's owners was HKD 0.35, compared to a basic loss per share of HKD 0.67 in the same period of 2024 [1]

Core Viewpoint - Xinyu Environmental (00436) reported a mid-year performance for 2025, indicating a slight decline in revenue and a significant reduction in loss compared to the previous year [1] Financial Performance - Revenue for the period was approximately HKD 165 million, representing a year-on-year decrease of 0.6% [1] - The loss attributable to the company's owners was approximately HKD 10.619 million, which is a 47.6% decrease year-on-year [1] - Basic loss per share was reported at HKD 0.35 cents [1]

Group 1 - The company reported a revenue of approximately HKD 165 million for the first half of 2025, representing a year-on-year decrease of 0.6% [1] - The loss attributable to the owners of the company was approximately HKD 10.619 million, which is a year-on-year decrease of 47.6% [1] - The basic loss per share was HKD 0.35 [1]